FPMAJ Accepts PMDA’s Fee Raise Plan, but Wants Tradeoff

The Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ) has accepted the Pharmaceuticals and Medical Devices Agency’s (PMDA) plan to raise its drug review fees, but it is urging the agency to present specific benefits it could get from such...read more